Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05078151
What this trial is testing

Whole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Vall d'Hebron Institute of Oncology 69
Testing effectiveness (Phase 2)Study completedNCT04523207
What this trial is testing

Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 108
Early research (Phase 1)Active Not RecruitingNCT07236112
What this trial is testing

Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate Cancer

Who this might be right for
Prostate Cancer
C Ray Therapeutics 6
Testing effectiveness (Phase 2)Study completedNCT00003781
What this trial is testing

Docetaxel in Treating Patients With Stage IV Prostate Cancer

Who this might be right for
PainProstate Cancer
OHSU Knight Cancer Institute 25
Testing effectiveness (Phase 2)Looking for participantsNCT05720130
What this trial is testing

Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerMetastatic Hormone Sensitive Prostate Cancer
AdvanCell Pty Limited 100
Not applicableWithdrawnNCT00161252
What this trial is testing

Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly

Who this might be right for
Prostate Cancer
University of Medicine and Dentistry of New Jersey
Very early researchStudy completedNCT04726033
What this trial is testing

64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study)

Who this might be right for
Metastatic Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 14
Large-scale testing (Phase 3)Study completedNCT01715285
What this trial is testing

Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 1,209
Not applicableStudy completedNCT01812668
What this trial is testing

Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Barbara Ann Karmanos Cancer Institute 20
Large-scale testing (Phase 3)Study completedNCT00005947
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Dendreon 127
Testing effectiveness (Phase 2)Study completedNCT00283829
What this trial is testing

Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 30
Testing effectiveness (Phase 2)Study completedNCT00942578
What this trial is testing

Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
National Cancer Institute (NCI) 63
Post-approval studies (Phase 4)Ended earlyNCT04134208
What this trial is testing

An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
M.D. Anderson Cancer Center 2
Not applicableActive Not RecruitingNCT04067713
What this trial is testing

Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
University College, London 192
Testing effectiveness (Phase 2)Study completedNCT01923727
What this trial is testing

Phase I/IIA Study of PET Imaging With 89Zr-Df-IAB2M in Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
ImaginAb, Inc. 38
Very early researchStudy completedNCT05773703
What this trial is testing

Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Ratio Therapeutics, Inc. 23
Not applicableStudy completedNCT01062503
What this trial is testing

Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC

Who this might be right for
Metastatic Prostate CancerBone Metastasis
University Health Network, Toronto 48
Large-scale testing (Phase 3)Looking for participantsNCT05796973
What this trial is testing

Measuring Oncological Value of Exercise and Statin

Who this might be right for
Prostate CancerBreast CancerKidney Cancer+9 more
Tampere University Hospital 240
Large-scale testing (Phase 3)Active Not RecruitingNCT03241537
What this trial is testing

COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer

Who this might be right for
Prostate Neoplasm
Samsung Medical Center 61
Testing effectiveness (Phase 2)Study completedNCT00089609
What this trial is testing

Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 73
Next Page